Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 831 of 1,261

  1. US 8648102

    Compounds for treatment of cell proliferative diseases

    The Board of Regents of the University of Texas System · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  2. US 8646246

    Method of preparing a composition in blister packages

    Quantum Hi-Tech (Beijing) Research Institute · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  3. US 8647633

    Recombinant F1-V plague vaccine

    The United States of America as represented by the Secretary of the Army · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  4. US 8642788

    Activators of executioner procaspases 3, 6 and 7

    The Regents of the University of California · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  5. US 8642784

    Biologically active compound N-[3-(4-nitrophenylamino)-indole-2-ilmethylene]aminoguanidine hydrochloride with anti-inflammatory activity

    Obschestvo S Ogranichennoy Otvetstvennostyu “Polyar” (OOO Polyar) · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  6. US 8642770

    Indole derivative

    Takeda Pharmaceutical Company Limited · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  7. US 8642751

    MicroRNA inhibitors comprising locked nucleotides

    MIRAGEN THERAPEUTICS, INC. · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  8. US 8642738

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  9. US 8642656

    Calixarene-based peptide conformation mimetics, methods of use, and methods of making

    Regents of the University of Minnesota · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  10. US 8642653

    Ketone compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  11. US 8642741

    Human antibodies to human TNF-like ligand 1A (TL1A)

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  12. US 8642550

    Chimeric natriuretic peptides without hypotensive inducing capability

    Regents of the University of Minnesota · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  13. US 8642076

    Lipid containing formulations

    Tekmira Pharmaceuticals Corporation · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  14. US 8642649

    Orally dispersible tablet

    Takeda Pharmaceutical Company Limited · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  15. US 8642107

    Water formulation with herbal hint and a process therefor

    Century Biologicals Private Limited · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  16. US 8642648

    Orally dispersible tablet

    Takeda Pharmaceutical Company Limited · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  17. US 8642604

    Substituted pyrazolo[3,2-d]pyrimidines as anti-cancer agents

    The Regents of the University of California · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  18. US 8642561

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  19. US 8642614

    Toll-like receptor modulators and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  20. US 8642593

    2,4-pyrimidinediamine compounds and prodrugs and their uses

    Rigel Pharmaceuticals, Inc. · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  21. US 8642282

    Inhibitors of nitric oxide synthase for treatment of melanoma

    The Regents of the University of California · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  22. US 8642539

    Method for treating a disease characterized by reduced appetite

    Takeda Pharmaceutical Company Limited · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  23. US 8642081

    Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance

    TAKEDA NYCOMED AS · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  24. US 8642534

    Proteins and polynucleotides of Vibrio cholerae

    The Regents of the University of California · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.